Quality improvement in acute stroke - The New York State Stroke Center Designation Project

被引:112
作者
Gropen, T. I.
Gagliano, P. J.
Blake, C. A.
Sacco, R. L.
Kwiatkowski, T.
Richmond, N. J.
Leifer, D.
Libman, R.
Azhar, S.
Daley, M. B.
机构
[1] Long Isl Coll Hosp, Dept Neurol, Brooklyn, NY 11201 USA
[2] SUNY Hlth Sci Ctr, IPRO, Brooklyn, NY 11203 USA
[3] New York State Dept Hlth, Healthcare Qual Initiat, New York, NY USA
[4] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA
[5] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY USA
[6] Long Isl Jewish Med Ctr, Dept Emergency Med, New Hyde Pk, NY 11042 USA
[7] Long Isl Jewish Med Ctr, Div Cerebrovasc Dis, New Hyde Pk, NY 11042 USA
[8] Long Isl Jewish Med Ctr, New Hyde Pk, NY 11042 USA
[9] N Shore Univ Hosp, Dept Neurol, Manhasset, NY USA
[10] Cornell Univ, New York Presbyterian Hosp, Weill Med Coll, Dept Neurol, New York, NY 10021 USA
[11] Lutheran Med Ctr, Stroke Ctr, Brooklyn, NY USA
[12] New York City Fire Dept, Louisville, KY USA
[13] Louisville Metro EMS, Louisville, KY USA
关键词
ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; EMERGENCY; ESTABLISHMENT; CARE;
D O I
10.1212/01.wnl.0000223622.13641.6d
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Many hospitals lack the infrastructure required to treat patients with acute stroke. The Brain Attack Coalition (BAC) published guidelines for the establishment of primary stroke centers. Objective: To determine if stroke center designation and selective triage of acute stroke patients improve quality of care. Methods: Baseline chart abstraction was performed on all stroke patients admitted to 32 hospitals serving Brooklyn and Queens, NY, from March to May 2002. Hospitals were invited to meet BAC guideline-based criteria. Adherence was verified by on-site visits. After designation, acute stroke patients were selectively triaged. Remeasurement data were collected from August to October 2003. Results: The authors abstracted 1,598 charts at baseline and 1,442 charts at remeasurement. From baseline to remeasurement, median times decreased for door to physician contact (25 vs 15 minutes, p = 0.001), CT performance for potential tissue plasminogen activator (t-PA) candidates (68 vs 32 minutes, p < 0.001), and t-PA administration ( 109 vs 98 minutes (p = NS). IV t-PA utilization increased from 2.4 to 5.2% (p < 0.005), select t-PA protocol violations decreased from 11.1 to 7.9% ( p = NS), and the stroke unit admission rate increased from 16 to 39% (p < 0.001). In stroke centers (n = 14) vs nondesignated hospitals (n = 18), there were shorter median times from door to physician contact (10 vs 25 minutes, p < 0.001), CT performance for potential t-PA candidates (31 vs 40 minutes, p = NS), and t-PA administration (95 vs 115 minutes, p < 0.05). Stroke centers, compared with nondesignated centers, admitted acute stroke patients to stroke units more often (55.9 vs 10.9%, p < 0.001). Conclusions: Stroke center designation and selective triage of acute stroke patients improved the quality of care, including access to timely thrombolytic therapy and stroke units.
引用
收藏
页码:88 / 93
页数:6
相关论文
共 21 条
  • [1] Guidelines for the early management of patients with ischemic stroke - A scientific statement from the Stroke Council of the American Stroke Association
    Adams, HP
    Adams, RJ
    Brott, T
    del Zoppo, GJ
    Furlan, A
    Goldstein, LB
    Grubb, RL
    Higashida, R
    Kidwell, C
    Kwiatkowski, TG
    Marler, JR
    Hademenos, GJ
    [J]. STROKE, 2003, 34 (04) : 1056 - 1083
  • [2] Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study
    Albers, GW
    Bates, VE
    Clark, WM
    Bell, R
    Verro, P
    Hamilton, SA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09): : 1145 - 1150
  • [3] Recommendations for the establishment of primary stroke centers
    Alberts, MJ
    Hademenos, G
    Latchaw, RE
    Jagoda, A
    Marler, JR
    Mayberg, MR
    Starke, RD
    Todd, HW
    Viste, KM
    Girgus, M
    Shephard, T
    Emr, M
    Shwayder, P
    Walker, MD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (23): : 3102 - 3109
  • [4] Asplund K, 1997, BMJ-BRIT MED J, V314, P1151
  • [5] Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice
    Chiu, D
    Krieger, D
    Villar-Cordova, C
    Kasner, SE
    Morgenstern, B
    Bratina, PL
    Yatsu, FM
    Grotta, JC
    [J]. STROKE, 1998, 29 (01) : 303 - 303
  • [6] Do the Brain Attack Coalition's criteria for stroke centers improve care for ischemic stroke?
    Douglas, VC
    Tong, DC
    Gillum, LA
    Zhao, S
    Brass, LM
    Dostal, J
    Johnston, SC
    [J]. NEUROLOGY, 2005, 64 (03) : 422 - 427
  • [7] Delay between stroke onset and emergency department evaluation
    Goldstein, LB
    Edwards, MG
    Wood, DP
    [J]. NEUROEPIDEMIOLOGY, 2001, 20 (03) : 196 - 200
  • [8] North Carolina stroke prevention and treatment facilities survey - Statewide availability of programs and services
    Goldstein, LB
    Hey, L
    Laney, R
    [J]. STROKE, 2000, 31 (01) : 66 - 70
  • [9] Early intravenous thrombolysis for acute ischemic stroke in a community-based approach
    Grond, M
    Stenzel, C
    Schmülling, S
    Rudolf, J
    Neveling, M
    Lechleuthner, A
    Schneweis, S
    Heiss, WD
    [J]. STROKE, 1998, 29 (08) : 1544 - 1549
  • [10] Quality improvement and tissue-type plasminogen activator for acute ischemic stroke - A Cleveland update
    Katzan, IL
    Hammer, MD
    Furlan, AJ
    Hixson, ED
    Nadzam, DM
    [J]. STROKE, 2003, 34 (03) : 799 - 800